About this trial
This study aims to evaluate the clinical efficacy of traditional Chinese medicine formula granules (Fei Re Qing Granules) in the treatment of elderly community-acquired pneumonia, establish a treatment protocol, and obtain high-level clinical evidence.
Eligibility criteria
Qualifiers
Inpatients diagnosed with community-acquired pneumonia (CAP) according to the diagnostic criteria.
Diagnosed with Phlegm-Heat Obstructing the Lungs syndrome based on Traditional Chinese Medicine (TCM).
Aged ≥65 and ≤80 years, regardless of gender.
Onset of illness within 72 hours.
Disqualifiers
Patients with altered mental status, consciousness disorders, dementia, or psychiatric disorders.
Patients requiring invasive mechanical ventilation or endotracheal intubation.
Patients with conditions such as pleural effusion, bronchiectasis, active pulmonary tuberculosis, pulmonary abscess, lung cancer, asthma, or chronic obstructive pulmonary disease (COPD).
Patients with neuromuscular diseases or those bedridden for long periods, posing a risk of aspiration.
Trial design
Treatments tested in this trial
- Fei Re Qing Granules
- Routine standard treatments
- Placebo granules
Treatment groups
Locations
Sponsors and collaborators
Henan University of Traditional Chinese Medicine
Lead sponsor
Third Affiliated Hospital of Henan University of Traditional Chinese Medicine
Collaborator
The First Affiliated Hospital of Henan university of CM
Collaborator